BNP Paribas Financial Markets’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-476
| Closed | -$46.4K | – | 3732 |
|
|
2015
Q1 | $46.4K | Buy |
+476
| New | +$46.4K | ﹤0.01% | 1960 |
|
|
2014
Q4 | – | Sell |
-1,290
| Closed | -$88.7K | – | 3495 |
|
|
2014
Q3 | $88.7K | Buy |
1,290
+1,226
| +1,916% | +$84.3K | ﹤0.01% | 1892 |
|
|
2014
Q2 | $6.71K | Buy |
+64
| New | +$6.71K | ﹤0.01% | 2002 |
|
|
2014
Q1 | – | Sell |
-248
| Closed | -$16.1K | – | 3541 |
|
|
2013
Q4 | $16.1K | Sell |
248
-4,461
| -95% | -$289K | ﹤0.01% | 1919 |
|
|
2013
Q3 | $299K | Sell |
4,709
-1,656
| -26% | -$105K | ﹤0.01% | 1648 |
|
|
2013
Q2 | $267K | Buy |
+6,365
| New | +$267K | ﹤0.01% | 1803 |
|